← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 6, 2021Last known activity
Jan 1, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 7 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Recent trials (18)
- NCT07301775CollaboratorPhase 4Jan 1, 2026
- NCT07290595Lead sponsorPhase 2/Phase 3Jan 13, 2025
- NCT07290595Sponsor investigatorPhase 2/Phase 3Jan 13, 2025
- NCT07290595OfficialPhase 2/Phase 3Jan 13, 2025
- NCT06740903OfficialPhase 2/Phase 3Aug 6, 2024
- NCT06740903Lead sponsorPhase 2/Phase 3Aug 6, 2024
- NCT06740903Sponsor investigatorPhase 2/Phase 3Aug 6, 2024
- NCT06728514Sponsor investigatorPhase 2/Phase 3Jan 11, 2024
- NCT06728514OfficialPhase 2/Phase 3Jan 11, 2024
- NCT06728514Lead sponsorPhase 2/Phase 3Jan 11, 2024
- NCT06531603Sponsor investigatorPhase 2/Phase 3Feb 20, 2022
- NCT06531603Lead sponsorPhase 2/Phase 3Feb 20, 2022
- NCT06531603OfficialPhase 2/Phase 3Feb 20, 2022
- NCT06707051Lead sponsorPhase 2/Phase 3Jan 1, 2022
- NCT06707051Sponsor investigatorPhase 2/Phase 3Jan 1, 2022
Details
- Last known activity
- Jan 1, 2026